Based on this analysis, all 3 gepants are not cost-effective compared with usual care for the treatment of acute migraine. Objective: Migraine is a debilitating chronic disorder requiring multifaceted ...

This article originally appeared on PolitiFact. The federal shutdown — one month long and counting — has an obvious economic impact for government workers who aren’t receiving paychecks and food aid ...

Introduction: Seasonal influenza is a major cause of illness and death worldwide. Vaccination remains the cornerstone of prevention, with options including trivalent inactivated (TIV), quadrivalent ...

Students will be able to filter for NO COST and LOW COST courses during registration. This initiative supports transparency and affordability, and it’s a priority for our students. While it’s part of ...

For the past five years, Kyle K. Courtney, who directs copyright and information policy for Harvard’s libraries, has fought to make e-books more accessible to public libraries across the United States ...

A few months after the release of Grok 4 and an extremely problematic antisemitic meltdown of its chatbot, xAI is already trying to move on with its latest AI model. Elon Musk's xAI announced the ...

A new analysis from the Institute for Clinical and Economic Review has found that blockbuster GLP-1 drugs from Novo Nordisk and Eli Lilly offer substantial health benefits and are a cost-effective ...

ICER rates semaglutide and tirzepatide as cost effective vs lifestyle modifications Lilly's tirzepatide shows "promising but inconclusive" cost-effectiveness vs Novo's semaglutide Net prices of both ...

Amid a yearslong wave of enthusiasm and uptake for Eli Lilly and Novo Nordisk's blockbuster obesity medicines, the drugs have scored a strong endorsement from an independent U.S. cost watchdog. In a ...

Ed Silverman, a senior writer and Pharmalot columnist at STAT, has been covering the pharmaceutical industry for nearly three decades. He is also the author of the morning Pharmalittle newsletter and ...

As countries race to scale up nuclear power to meet climate goals and fuel power-hungry data centers, a longstanding problem persists: Nuclear plants are notoriously expensive to build. But China is ...